On Feb.21, 2012, the company conducted the first Investigators Meeting in Treatment of Re-evaluation of Nerve Root Cervical Spondylosis in Shanghai Equatorial Hotel. Leaders of Science and Education Department of Shanghai Municipal Health Bureau and Shanghai Municipal Science and Technology Commission of Biotech Pharmaceutical Department, principal investigators in cooperation unit of various subjects are invited to participate in this project. The meeting was hosted by Ms. Wang Biquan, the company's deputy general manager, and addressed by Mr. Bian Huashi, the company’s general manager. During the meeting, the principle investigators and clinical trial contract research organization (CRO) of Qi She Pill conducted an in-depth discussion on the evaluation of the programme and organizational management modes and proposed the constructive solutions and measures. Mr. Zhang Kan, the division chief of Shanghai Municipal Bureau of Health Science and Education Department, delivered the concluding remarks at the meeting. He clearly indicated that the re-evaluation investigation should be accelerated. It’s prospected that the close integration between company and various hospitals in the re-evaluation of Qi She Pill’s research project should be conducted to make a contribution in the standardization and modernization of traditional Chinese medicine products.